Vita 34 AG buy kostojunior
Start price
18.03.16
/
50%
€4.60
Target price
01.04.16
€4.99
Performance (%)
0.00%
End price
01.04.16
€4.60
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vita 34 AG | -3.937% | -3.937% | 48.780% | -24.877% |
| iShares Core DAX® | 0.765% | 4.791% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 1.418% | 3.133% | 5.422% | 113.046% |
| iShares Nikkei 225® | 0.658% | 0.972% | 15.333% | 47.267% |
| iShares S&P 500 | 1.310% | 2.279% | 3.125% | 68.687% |
According to kostojunior what are the pros and cons of Vita 34 AG for the foreseeable future?
Pros
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
positive Cash Flow expected
Standard Investments for future growth
Cons
Comments by kostojunior for this prediction
In the thread Vita 34 AG diskutieren
Chart + Fundamental
start 4,55
-------------------------------------------------------------------------
kj (auf dem Weg zurück in die TOP100, -aktuell 443.)
Current prediction by kostojunior for Vita 34 AG
Vita 34 AG
Start price
Target price
Perf. (%)
€5.90
20.12.25
20.12.25
€7.00
20.12.26
20.12.26
3.39%
23.12.25
23.12.25
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Stopped prediction by kostojunior for Vita 34 AG
Vita 34 AG
Start price
Target price
Perf. (%)
€4.80
20.07.25
20.07.25
-
20.07.26
20.07.26
2.92%
02.08.25
02.08.25
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.28
15.04.25
15.04.25
€9.00
15.04.26
15.04.26
-0.47%
26.04.25
26.04.25
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.76
19.09.23
19.09.23
€6.00
19.09.24
19.09.24
-1.68%
30.09.23
30.09.23
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.79
07.09.23
07.09.23
-
07.09.24
07.09.24
-4.59%
16.09.23
16.09.23
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Vita 34 AG
Start price
Target price
Perf. (%)
€11.05
18.05.22
18.05.22
-
18.05.23
18.05.23
-0.45%
28.05.22
28.05.22
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Vita 34 AG
Start price
Target price
Perf. (%)
€15.55
21.02.21
21.02.21
-
21.02.22
21.02.22
-25.08%
22.02.22
22.02.22
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.57
19.05.16
19.05.16
€4.99
21.11.16
21.11.16
8.32%
21.11.16
21.11.16
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.94
11.11.15
11.11.15
€5.55
01.12.15
01.12.15
2.25%
01.12.15
01.12.15
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Vita 34 AG
Start price
Target price
Perf. (%)
€5.24
08.09.15
08.09.15
€15.00
21.09.15
21.09.15
2.73%
21.09.15
21.09.15
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Vita 34 AG
Start price
Target price
Perf. (%)
€2.88
23.03.13
23.03.13
€4.44
23.09.13
23.09.13
-1.94%
23.09.13
23.09.13
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected


